tweetindex
DE

UroToday.com

@urotoday · Reno, NV · joined 19 Feb 2009

Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology

31 264Followers
5 984Following
126 094Posts total
1.9KViews on collected posts

Neueste Beiträge

PSMA PET interpretation in biochemical recurrence after #ProstateCancer treatment. Steve Cho, MD joins @tranpt21 highlighting that detection is most reliable at PSA 0.2–0.5 ng/mL—below this, a negative scan does not exclude disease. ✅ Small PSMA-avid lymph nodes can be highly htt
44 views · 0 likes · 0 reposts · 0 replies Open on X →
CAPItello-281 and the PTEN-deficient subset of metastatic hormone-sensitive #ProstateCancer. @CaPsurvivorship @danafarber joins @neerajaiims @huntsmancancer to discuss CAPItello-281. The trial supported the approval of capivasertib + abiraterone in PTEN-deficient #mHSPC, a https:
128 views · 0 likes · 0 reposts · 0 replies Open on X →
Radiopharmaceuticals in #ProstateCancer: Payloads, Carriers, Targets, and Combinations. Michael Morris, MD @MSKCancerCenter & @DrRanaMcKay @UCSanDiego join @DrPhilKantoff @ConvergentRx to discuss isotope and carrier selection, combination strategies, and emerging targets in https
138 views · 1 likes · 0 reposts · 0 replies Open on X →
Patient-reported outcomes with EV-pembrolizumab vs cystectomy alone in #MIBC. Peter O'Donnell, MD @UChicagoMed joins @ERPlimackMD @FoxChaseCancer sharing a PRO analysis from KEYNOTE-905 comparing EV + pembrolizumab against cystectomy alone in muscle-invasive #BladderCancer. The h
280 views · 3 likes · 0 reposts · 0 replies Open on X →
Multidisciplinary teams to address quality and documentation of bladder tumor resection. @pjhensley11 @UKYMedicine sits down with @UroDocAsh @UTMDAnderson to discuss the IBCG 2026 focus on TURBT quality, marking the first time the retreat has centered on a procedure rather than a
292 views · 0 likes · 0 reposts · 0 replies Open on X →
First interim analysis of SWOG S1823/GCC.1: Operating characteristics of circulating microRNA 371a-3p (miR371) in predicting active germ cell malignancy (aGCM) in patients with early-stage #TesticularCancer. Presentation by @LuciaNappi4 @VanProstateCtr. #ASCO26 written coverage h
1.1K views · 9 likes · 8 reposts · 0 replies Open on X →

Im Vergleich zu Konten gleicher Größe

5 Beiträge aus den letzten 90 Tagen, verglichen mit der Größenklasse 10K–100K Follower. erreicht weniger Menschen als Konten gleicher Größe.

Medianaufrufe138dieses Konto914Median für 10K–100K
Reichweite, %0.44%dieses Konto3.38%Median für 10K–100K
Interaktion, %0.00%dieses Konto1.53%Median für 10K–100K
KennzahlDieses KontoMedian für 10K–100KVerhältnis
Medianaufrufe pro Beitrag1389140.15×
Reichweite (Aufrufe ÷ Follower)0.44%3.38%0.13×
Interaktionsrate0.00%1.53%0.00×

Weitere Konten dieser Größe →   Mit einem anderen Konto vergleichen →   Wie diese Vergleichswerte entstehen →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.1K31 May
29216 Sep
280
138
128
44

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.71%31 May
0.00%16 Sep
1.07%
0.72%
0.00%
0.00%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.53%.

What the audience does

Likes59.1%13 in total
Reposts36.4%8 in total
Quotes4.5%1 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Ähnliche Konten